OR WAIT null SECS
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Stefan Merlo, Vice President, Commercial Development, CSL Seqirus discusses how COVID-19 has evolved the discussion of vaccines and the long-term concerns stemming from flu vaccine fatigue.
At Pharma 2023 in Barcelona, Stefan Merlo, Vice President, Commercial Development at CSL Seqirus, discussed the global vaccine journey, the connected customer experience and the role of consumer and government education to improve public health.